GENEius

Jnetics

RAISED SO FAR
£210,990
£209,865 exc. gift aid
DONATIONS
178
TARGET
£300,000
see donations list
Anonymous donation of £250.00 with £62.50 gift aid on 29/10/2017 at 17:51. £250.00
From Anonymous
Anonymous
Amount
£250.00
Date/Time
29/10/2017 17:51:59
Gift Aid
£62.50
Type
One Off
Anonymous donation of £100.00 with £25.00 gift aid on 21/09/2017 at 22:38. £100.00
From Anonymous
Anonymous
Amount
£100.00
Date/Time
21/09/2017 22:38:12
Gift Aid
£25.00
Type
One Off
Anonymous donation of £350.00 with £87.50 gift aid on 15/09/2017 at 10:00. £350.00
From Anonymous
Anonymous
Amount
£350.00
Date/Time
15/09/2017 10:00:10
Gift Aid
£87.50
Type
One Off
Anonymous donation of £100.00 with £25.00 gift aid on 09/04/2017 at 19:27. £100.00
From Anonymous
Anonymous
Amount
£100.00
Date/Time
09/04/2017 19:27:09
Gift Aid
£25.00
Type
One Off

Also Fundraising For This Appeal

Show More
Charity Registration No: 1134935

Jnetics is the only charity that is dedicated to improving the prevention and management of Jewish genetic disorders in the UK.

Our activities focus on 3 core areas: awareness-raising, signposting the best available information, services and support, and facilitating access to responsible genetic screening options.

Jnetics was established to raise awareness in the Jewish community and among healthcare professionals, and to help those affected and at risk access the best available information, services and support.

We are also dedicated to facilitating access to responsible genetic testing service and have established the first and only community screening programme for a group of severe genetic conditions that disproportionally affect Jewish people.

Jnetics has recently launched the GENEius programme; a pioneering education and screening initiative targeting young Jewish adults in 3 main groups; sixth form students, university students, and couples going through the synagogue pre-marriage process.

GENEius aims to eliminate the birth of children in the UK Jewish Community with any of nine preventable severe life-shortening recessive JGDs; and to improve awareness and management of the risks associated with hereditary BRCA-related cancers that also disproportionately affect Jewish people.

Visit Our Profile Page